Immix Biopharma Inc. (IMMX)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
2.02
-0.04 (-1.94%)
At close: Jan 17, 2025, 3:59 PM
2.08
2.97%
After-hours Jan 17, 2025, 04:48 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
PE Ratio | -7.78 | -3.68 | -1.93 | -24.85 | -12.73 |
PS Ratio | n/a | -0.34 | n/a | n/a | n/a |
PB Ratio | 7.31 | 2.30 | 2.62 | -6.03 | -3.4 |
P/FCF Ratio | -10.5 | -4.09 | -29.62 | -70.5 | -15.53 |
P/OCF Ratio | -10.55 | -4.09 | -29.63 | -70.5 | -15.68 |
OCF/S Ratio | n/a | 0.08 | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | 0.00 | -0.87 | -1.12 |
Quick Ratio | 5.32 | 11.70 | 90.01 | 0.10 | 0.20 |
Current Ratio | 5.32 | 11.70 | 90.01 | 0.10 | 0.20 |
Asset Turnover | n/a | -6 | n/a | n/a | n/a |
Interest Coverage | n/a | -16.54K | -7.52 | -4.45 | -7.66 |
Return on Equity (ROE) | -0.94 | -0.63 | -1.36 | 0.24 | 0.27 |
Return on Assets (ROA) | -0.77 | -0.55 | -1.34 | -2.13 | -1.03 |
Return on Capital (ROIC) | -1 | -0.6 | -0.08 | 0.10 | 0.23 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | 100.00% | n/a | n/a | n/a |
Net Profit Margin | n/a | 9.19% | n/a | n/a | n/a |
Pretax Profit Margin | n/a | 9.18% | n/a | n/a | n/a |
Operating Profit Margin | n/a | 9.18% | n/a | n/a | n/a |
FCF Margin | n/a | 8.28% | n/a | n/a | n/a |
EBITDA Margin | n/a | 9.18% | n/a | n/a | n/a |